Craig Lindsley Archives
ASPET honors Lindsley’s pharmacology research
Feb. 27, 2014—Vanderbilt University’s Craig Lindsley, Ph.D., has won the 2014 John J. Abel Award in Pharmacology for young investigators from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
New approach may halt glioblastoma’s ability to grow
Jan. 16, 2014—Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer.
2013 Academic Enterprise Faculty Awards
May. 23, 2013—The 2013 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during Wednesday’s Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Award recipients were nominated by their faculty colleagues and chosen by the Academic Enterprise Faculty Awards Selection Committee.
Lindsley honored for impact on medicinal chemistry field
Mar. 14, 2013—Vanderbilt University’s Craig Lindsley, Ph.D., is the 2013 recipient of the Philip S. Portoghese Lectureship, awarded jointly by the Journal of Medicinal Chemistry and the American Chemical Society (ACS) Division of Medicinal Chemistry.
Nobel in Chemistry reveals VU ties that bind
Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
VU, Bristol-Myers to collaborate on Parkinson’s therapies
Sep. 21, 2012—Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
Event celebrates Vanderbilt endowed chair holders
Aug. 30, 2012—Twelve Vanderbilt University faculty members were honored for extraordinary contributions to their respective fields during an Aug. 28 celebration of endowed chair holders at the Student Life Center.
Minds wide open: Neuroscience at Vanderbilt
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Drug-like molecules aimed at improving treatment of Parkinson’s
Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.
Neuroscience drug discovery center opens at Vanderbilt
Mar. 11, 2011—Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain.
